FMA Advisory’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

FMA Advisory’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$11K	Buy	+28	New	+$11.9K	0.01%	279

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FMA Advisory's LUMO Position: Q2 2015 in Review

FMA Advisory opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2015: 28 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #279 among its holdings.

145 funds tracked by Wall St. Rank hold LUMO as of Q2 2015.

FMA Advisory held 28 shares of Lumos Pharma, Inc. Common Stock worth $11K as of Q2 2015.
Lumos Pharma, Inc. Common Stock was a new FMA Advisory position in Q2 2015.
Lumos Pharma, Inc. Common Stock made up 0.01% of FMA Advisory's portfolio in Q2 2015, its #279 holding.
145 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.